Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 29/11/2011
PIL Campto 20mg/ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
Updated on 01/07/2011 and displayed until 29/11/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change due to user-testing of patient information
Updated on 08/11/2010 and displayed until 01/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 16/09/2009 and displayed until 08/11/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 15/05/2009 and displayed until 16/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to side-effects
  • Change to drug interactions
  • Changes to therapeutic indications
Updated on 09/02/2009 and displayed until 15/05/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 08/01/2009 and displayed until 09/02/2009
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 02/06/2008 and displayed until 08/01/2009
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 07/05/2008 and displayed until 02/06/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 12/02/2008 and displayed until 07/05/2008
Reasons for adding or updating:
  • Change to packaging
  • Introduction of new pack
  • Introduction of new pack/pack size
  • Change to date of revision
  • Change of special precautions for disposal
Updated on 24/05/2007 and displayed until 12/02/2008
Reasons for adding or updating:
  • Change of manufacturer
Updated on 13/04/2007 and displayed until 24/05/2007
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 26/02/2007 and displayed until 13/04/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Changes to therapeutic indications
  • Change to date of revision
Updated on 17/08/2006 and displayed until 26/02/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 03/06/2005 and displayed until 17/08/2006
Reasons for adding or updating:
  • Change of licence holder
Updated on 30/09/2004 and displayed until 03/06/2005
Reasons for adding or updating:
  • Change to drug interactions
  • Change of contra-indications
Updated on 17/09/2003 and displayed until 30/09/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  irinotecan hydrochloride trihydrate